Diagnosis of antiphospholipid antibodies

Research output: Contribution to journalArticle

Abstract

The antiphospholipid antibody syndrome consists of a presentation with venous thrombosis, arterial thrombosis (or vasculopathy), recurrent pregnancy loss, or thrombocytopenia, in the setting of high-titer anticardiolipin antibody or lupus anticoagulant. Characteristics of the lupus anticoagulant (an antibody detected by a functional assay) and anticardiolipin antibody are reviewed, in light of new information on the role of plasma proteins, especially B2- glycoprotein I. The advantages and disadvantages of screening and confirmatory assays for lupus anticoagulant are detailed, as well as modifications of the anticardiolipin antibody assay to improve sensitivity and specificity.

Original languageEnglish (US)
Pages (from-to)443-469
Number of pages27
JournalRheumatic Disease Clinics of North America
Volume20
Issue number2
StatePublished - 1994

Fingerprint

Lupus Coagulation Inhibitor
Anticardiolipin Antibodies
Antiphospholipid Antibodies
Antiphospholipid Syndrome
Venous Thrombosis
Thrombocytopenia
Blood Proteins
Glycoproteins
Thrombosis
Sensitivity and Specificity
Pregnancy
Antibodies

ASJC Scopus subject areas

  • Rheumatology

Cite this

Diagnosis of antiphospholipid antibodies. / Petri, Michelle.

In: Rheumatic Disease Clinics of North America, Vol. 20, No. 2, 1994, p. 443-469.

Research output: Contribution to journalArticle

@article{d850d4ced93843f683019601190cfdb3,
title = "Diagnosis of antiphospholipid antibodies",
abstract = "The antiphospholipid antibody syndrome consists of a presentation with venous thrombosis, arterial thrombosis (or vasculopathy), recurrent pregnancy loss, or thrombocytopenia, in the setting of high-titer anticardiolipin antibody or lupus anticoagulant. Characteristics of the lupus anticoagulant (an antibody detected by a functional assay) and anticardiolipin antibody are reviewed, in light of new information on the role of plasma proteins, especially B2- glycoprotein I. The advantages and disadvantages of screening and confirmatory assays for lupus anticoagulant are detailed, as well as modifications of the anticardiolipin antibody assay to improve sensitivity and specificity.",
author = "Michelle Petri",
year = "1994",
language = "English (US)",
volume = "20",
pages = "443--469",
journal = "Rheumatic Disease Clinics of North America",
issn = "0889-857X",
publisher = "W.B. Saunders Ltd",
number = "2",

}

TY - JOUR

T1 - Diagnosis of antiphospholipid antibodies

AU - Petri, Michelle

PY - 1994

Y1 - 1994

N2 - The antiphospholipid antibody syndrome consists of a presentation with venous thrombosis, arterial thrombosis (or vasculopathy), recurrent pregnancy loss, or thrombocytopenia, in the setting of high-titer anticardiolipin antibody or lupus anticoagulant. Characteristics of the lupus anticoagulant (an antibody detected by a functional assay) and anticardiolipin antibody are reviewed, in light of new information on the role of plasma proteins, especially B2- glycoprotein I. The advantages and disadvantages of screening and confirmatory assays for lupus anticoagulant are detailed, as well as modifications of the anticardiolipin antibody assay to improve sensitivity and specificity.

AB - The antiphospholipid antibody syndrome consists of a presentation with venous thrombosis, arterial thrombosis (or vasculopathy), recurrent pregnancy loss, or thrombocytopenia, in the setting of high-titer anticardiolipin antibody or lupus anticoagulant. Characteristics of the lupus anticoagulant (an antibody detected by a functional assay) and anticardiolipin antibody are reviewed, in light of new information on the role of plasma proteins, especially B2- glycoprotein I. The advantages and disadvantages of screening and confirmatory assays for lupus anticoagulant are detailed, as well as modifications of the anticardiolipin antibody assay to improve sensitivity and specificity.

UR - http://www.scopus.com/inward/record.url?scp=0028228924&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028228924&partnerID=8YFLogxK

M3 - Article

VL - 20

SP - 443

EP - 469

JO - Rheumatic Disease Clinics of North America

JF - Rheumatic Disease Clinics of North America

SN - 0889-857X

IS - 2

ER -